Unlabelled: Intra-abdominal fibromatosis (IAF) commonly develops in patients who had abdominal surgery. In rare instances, it occurs subsequent to gastrointestinal stromal tumor (GIST). This special situation has clinical significance in imatinib era. About 1000 patients with GIST in our institution from 1993 to 2010 were re-evaluated based on their clinical and pathological data, the treatment strategies and the follow-up information. We identified 2 patients who developed IAF after GIST resection. Patient 1 was a 54 year-old male and had 5 cm × 4.5 cm × 3.5 cm jejunal GIST excised on February 22, 1994. Three years later, an abdominal mass with 7 cm × 6 cm × 3 cm was identified. He was diagnosed as recurrent GIST from clinical point of view. After excision, the second tumor was confirmed to be IAF. Patient 2 was a 45-year-old male and had 6 cm × 4 cm × 3 cm duodenal GIST excised on August 19, 2008. One year later, a 4 cm mass was found at the original surgical site. The patient refused to take imatinib until the tumor increased to 8 cm six months later. The tumor continued to increase after 6 months' imatinib therapy, decision of surgical resection was made by multidisciplinary team. The second tumor was confirmed to be IAF with size of 17 cm × 13 cm × 11 cm. Although IAF subsequent to GIST is very rare, it is of clinical significance in imatinib era as an influencing factor for making clinical decision.

Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1076715989961803.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751073PMC
http://dx.doi.org/10.1186/1746-1596-8-125DOI Listing

Publication Analysis

Top Keywords

intra-abdominal fibromatosis
8
gastrointestinal stromal
8
stromal tumor
8
clinical significance
8
significance imatinib
8
imatinib era
8
gist excised
8
second tumor
8
tumor confirmed
8
confirmed iaf
8

Similar Publications

The patient was a 47-year-old woman. She had been aware of abdominal distension for several months and visited our hospital. Contrast CT revealed a 30 cm tumor with uneven contrast effect.

View Article and Find Full Text PDF
Article Synopsis
  • - Desmoid-type fibromatosis is a rare tumor that forms in deep soft tissues and doesn't spread to other parts of the body; the case revolves around a 78-year-old male with this condition found incidentally in the abdomen.
  • - Initial imaging revealed a large mass in the abdomen, leading to a successful surgery to remove the tumor and part of the small intestine, which confirmed the diagnosis of primary desmoid-type fibromatosis.
  • - Even after clear removal, the patient experienced a recurrence of the tumor 17 months later, necessitating another surgery, with a smooth recovery reported post-operation.
View Article and Find Full Text PDF

Aggressive fibromatosis of the sigmoid colon: A case report.

World J Gastrointest Oncol

August 2024

Department of Gastrointestinal and Anal Surgery, The Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, Zhejiang Province, China.

Article Synopsis
  • Aggressive fibromatosis (AF) is a rare type of benign but aggressive tumor that can grow in various body parts, including the abdomen, with a high chance of returning after surgery.* -
  • A unique case is reported where AF was found in the sigmoid colon of a 27-year-old woman during an unrelated surgical procedure, leading to its surgical removal.* -
  • The successful removal of the mass, confirmed as AF, resulted in a positive recovery with no recurrence observed after 30 months, indicating that surgical excision can be effective.*
View Article and Find Full Text PDF
Article Synopsis
  • Desmoid tumors (DTs) are uncommon, non-metastasizing growths that can behave aggressively locally, with a shift in management from traditional surgery to active surveillance.
  • A review of 103 patients showed a significant decrease in surgical resection rates over time, indicating a preference for monitoring rather than immediate intervention.
  • The study highlights improved treatment-free survival for those under active surveillance, aligning with updated guidelines from expert panels advocating for this approach.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!